Owen Adams Catherine sold ACAD
March 25, 2026 · Form 4 insider transaction
Owen Adams Catherine sold 11,641 shares of Acadia Pharmaceuticals Inc. at $21.47 per share, a transaction worth $249.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
11,641
Price
$21.47
Total value
$249.9K
InsiderOwen Adams Catherine
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 25, 2026
Filing dateMarch 26, 2026
Shares owned after14,803
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).